PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25294907-2	2014	Here, we report the development and therapeutic efficacy of a novel anti-RON antibody Zt/g4-maytansinoid (DM1) conjugates for targeted colorectal cancer (CRC) therapy.	zt	86-88	macrophage stimulating 1 receptor (c-met-related tyrosine kinase)	Mus musculus	73-76	
27102688-2	2016	Here we evaluated the efficacy of a novel anti-RON antibody-drug maytansinoid conjugate Zt/g4-DM1 for treatment of breast and NSCLC xenograft tumors in mouse models and explored a treatment strategy by combination of Zt/g4-DM1 with chemotherapeutics to achieve the maximal therapeutic activity.	zt	88-90	macrophage stimulating 1 receptor (c-met-related tyrosine kinase)	Mus musculus	47-50